Clinical Trials Logo

Filter by:
NCT ID: NCT04720755 Completed - Clinical trials for Erectile Dysfunction

Low Intensity Extracorporeal Shock Wave Therapy (Li-ESWT) for Erectile Dysfunction

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Low-intensity extracorporeal shock wave therapy (Li-ESWT) has shown promise as a novel treatment for erectile dysfunction (ED), though the the mechanism of action and optimal protocol for administration has not been well-established. The aim of this study is to assess for subjective and objective improvements in erectile function following treatment with Li-ESWT.

NCT ID: NCT04720703 Completed - Childhood Obesity Clinical Trials

A Theory Driven, Rurally Tailored, Family-Based, Telehealth Intervention for Childhood Obesity

Start date: August 15, 2021
Phase: N/A
Study type: Interventional

This pilot trial aims to improve the lives of individuals in rural Indiana by addressing the leading cause of death, obesity. The purpose is to help children and their families develop healthy behaviors to decrease childhood obesity. The short-term goal of this study to develop a prototype of theory-driven, tailored, family-based, telehealth intervention that can sustainably reduce pediatric obesity rates in rural areas. The long-term goal of this study is to sustainably reduce the rates of pediatric obesity and its consequences in rural areas, via behavioral change. It is hypothesized that after participating in this intervention, children will show improvement in age-based body mass index percentile and improved behavioral indicators related to nutrition, physical activity, sleep, and sedentary behaviors. Additionally, it is hypothesized that parents will show improved attitudes and skills for managing their child's behavior and improved perceived stress and perceived quality of life. Finally, levels of attendance, participation, and technology feasibility will indicate a successful intervention.

NCT ID: NCT04720599 Completed - Urologic Cancer Clinical Trials

Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy

Start date: June 1, 2020
Phase:
Study type: Observational

The study described here is being conducted to prospectively confirm the performance of the ExoDx Prostate gene expression assay in patients presenting for an initial prostate biopsy and support of CE-marking the test for a European Union Launch.

NCT ID: NCT04720547 Completed - Clinical trials for Sleep-disordered Breathing

Sleep and Breathing in the General Population - Chemical Stimuli

Start date: July 3, 2018
Phase: Phase 4
Study type: Interventional

Central sleep apnea (CSA) is a common condition and its treatment remains elusive. The focus of this proposal is to identify the role of the physiologic path involving cortical arousals in CSA by decreasing arousal frequency using the pharmacological agent zolpidem. The goal is to identify the acute effects of administering zolpidem on sleep and respiratory outcomes, and subsequently, its effect on the severity of CSA and propensity to develop CSA. This study will shed light on the mechanisms underlying CSA that involve cortical arousals and will guide future therapeutic interventions for CSA.

NCT ID: NCT04720534 Completed - Clinical trials for Severe Hypertriglyceridemia

Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia

SHASTA-2
Start date: May 31, 2021
Phase: Phase 2
Study type: Interventional

The purpose of AROAPOC3-2001 is to evaluate the efficacy and safety of ARO-APOC3 in participants with severe hypertriglyceridemia. Participants will receive 2 subcutaneous injections of ARO-APOC3.

NCT ID: NCT04720443 Completed - Clinical trials for Idiopathic Pulmonary Fibrosis

A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects

Start date: November 22, 2019
Phase: Phase 1
Study type: Interventional

This study is being conducted to evaluate the safety and tolerability of single ascending and multiple ascending oral doses of NIP292 tablets administered following an overnight fast in healthy adult subjects.

NCT ID: NCT04720430 Completed - Clinical trials for Hepatocellular Carcinoma

Blood Sample Collection for Experimental Blood Test to Track Liver Cancer

Start date: December 3, 2019
Phase:
Study type: Observational

This study investigates if an experimental blood test can help predict how well cancer will remain under control with treatment. Ther experimental blood test involves measuring mircoRNAs. MicroRNAs are small molecules which help regulate how genes are expressed. This information may help researchers guide treatment for other patients in the future.

NCT ID: NCT04720378 Completed - Clinical trials for Cytokine Release Syndrome

Safety and Tolerability Study of IV ST266 in COVID-19 Subjects

Start date: May 30, 2021
Phase: Phase 1
Study type: Interventional

The primary aim of the study is to evaluate the safety and tolerability of open-label ST266 given to subjects with confirmed COVID-19 infection through IV administration once a day of 5 consecutive days.

NCT ID: NCT04720300 Completed - Health Behavior Clinical Trials

Evaluating a Travel App's Influence on College Student Commuting to Campus

CTRAVELAPP
Start date: February 1, 2022
Phase: N/A
Study type: Interventional

The Cluster Randomized Controlled Trial (cRCT) portion of the study will focus on evaluating the use of information, marketing, and incentives to shape student travel behavior to campus through the three channels identified in Ajzen's (1991) framework.

NCT ID: NCT04720235 Completed - Covid19 Clinical Trials

A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit

Start date: December 9, 2020
Phase: N/A
Study type: Interventional

To evaluate the performance of the FDA EUA authorized Lucira COVID-19 All-In-One Test Kit for the qualitative detection of SARS-CoV-2 virus in nasal swab samples as compared to a known high sensitivity EUA RT-PCR among asymptomatic individuals. The comparator assay for this study is the Hologic Panther Fusion SARS-CoV-2 RT-PCR Assay.